Bausch Health Companies | VRX - Interest Income


Bausch Health Companies reported $11M in Interest Income for its fiscal quarter ending in June of 2026.





Interest Income Change Date
Aurora Cannabis CAD 1.04M 808K Mar/2026
Bausch Health Companies USD 11M 1000K Jun/2026
Biogen USD 37.9M 700K Mar/2026
Canopy Growth CAD 3.86M 1.89M Mar/2026
Corcept Therapeutics USD 4.89M 537K Mar/2026
Danaher USD 1.23 27M Jun/2026
Drreddys Laboratories INR 796M 332M Dec/2025
Eli Lilly USD 65M 25M Sep/2025
Gilead Sciences USD 95M 0 Mar/2026
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pacira USD 1.93M 365K Mar/2026
Phibro Animal Health USD 0.08 0.09 Dec/2024
Supernus Pharmaceuticals USD 2.38M 359K Mar/2026
Vertex Pharmaceuticals USD 114.8M 7.1M Mar/2026
Zoetis USD 21M 4M Mar/2026